Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interferons, immunity and cancer immunoediting.

Gavin P Dunn1, Catherine M Koebel, Robert D Schreiber

  • 1Washington University School of Medicine, Department of Pathology and Immunology, Box 8118, 660 South Euclid Avenue, St. Louis, Missouri 63110, USA.

Nature Reviews. Immunology
|October 26, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tumor infiltrating lymphocytes in glioblastoma: immunobiology and translational implications.

NPJ precision oncology·2026
Same author

Automating neoantigen selection for personalized cancer vaccine design.

medRxiv : the preprint server for health sciences·2026
Same author

pVACtools v6: A comprehensive suite for neoantigen prediction, visualization, and therapy design.

ArXiv·2026
Same author

A modular and flexible pipeline for intraoperative electrode reconstruction and localization in patients with brain lesions.

Frontiers in neural circuits·2026
Same author

IDH1-Associated m6A Methylation Is Linked to Transcriptomic Heterogeneity in Glioma.

Cancers·2026
Same author

Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trial.

Nature cancer·2026

Interferons (IFNs) are key regulators of the immune system's fight against cancer. This review details how type I and type II IFNs coordinate anti-tumor responses and influence cancer immunoediting.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • The host immune system plays a critical role in controlling cancer development.
  • Naturally occurring anti-tumor immune responses involve specific cells and molecules.
  • Interferons (IFNs) are central to the immune system's interaction with tumors.

Purpose of the Study:

  • To review the roles of type I (IFNalpha, IFNbeta) and type II (IFNgamma) interferons in cancer immunosurveillance.
  • To discuss the involvement of interferons in the broader process of cancer immunoediting.
  • To highlight the dynamic relationship between the immune system and cancer.

Main Methods:

  • Literature review of existing studies on interferons and cancer immunology.
  • Analysis of the functions of type I and type II interferons in anti-tumor immunity.

Related Experiment Videos

  • Synthesis of findings related to cancer immunosurveillance and immunoediting.

    • Main Results:

    • IFNgamma has a well-established role in promoting anti-tumor immune responses.
    • Type I interferons (IFNalpha, IFNbeta) have distinct and crucial functions in anti-tumor immunity.
    • Interferons act as central coordinators of tumor-immune system interactions.

    Conclusions:

    • Interferons are critical mediators of anti-tumor immunity.
    • Understanding interferon functions is essential for advancing cancer immunosurveillance and immunoediting research.
    • The study of interferons provides insights into the complex interplay between immunity and cancer.